In vitro metabolism of chlorpromazine by cytochromes P450 4F4 and 4F5 and the Inhibitory Effect of Imipramine

Neurotoxicity Research

Volumn 3, Issue 4, 2001, Pages 329-337

  Boehme, C ^a   Strobel, H W ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Chlorpromazine; Cytochromes; Imipramine

Indexed keywords

CHLORPROMAZINE; CHLORPROMAZINE SULFOXIDE; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; IMIPRAMINE; N DEMETHYLASE; NORCHLORPROMAZINE;

ANIMAL TISSUE; ARTICLE; BRAIN; CLONE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEMETHYLATION; DILUTION; DRUG EFFECT; DRUG METABOLISM; DRUG STRUCTURE; IN VITRO STUDY; INCUBATION TIME; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALIA;

EID: 0035173756     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033194     Document Type: Article

References (27)

1. Biotransformation of organic nitrates and vascular smooth muscle cell function
2. High-performance liquid chromatographic methods for the analysis of haloperidol and chlorpromazine metabolism in vitro by purified cytochrome P450 isoforms
3. Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons
4. Identification of a new P450 subfamily, CYP4F1, expressed in rat hepatic tumors
5. Pregnenolone and its sulfate ester in the rat brain
6. Nitric oxide formation during the cytochrome P-450-dependent reductive metabolism of 18-nitro-oxy-androstenedione
7. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it
8. MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation
9. Neurosteroids: Oligodendrocyte mitochondria convert cholesterol to pregnenolone
10. Purification and NH2-terminal amino acid sequences of human and rat kidney fatty acid omega-hydroxylases
11. Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain
12. Genomic cloning and protein expression of a novel rat brain cytochrome P-450 CYP2D18* catalyzing imipramine N-demethylation
13. cDNA cloning of three new forms of rat brain cytochrome P450 belonging to the CYP4F subfamily
14. A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. cDNA cloning and expression of leukotriene B4 omega- hydroxylase
15. Isolation of a new form of cytochrome P-450 with prostaglandin A and fatty acid omega-hydroxylase activities from rabbit kidney cortex microsomes
16. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
17. cDNA cloning and inducible expression during pregnancy of the mRNA for rabbit pulmonary prostaglandin omega-hydroxylase (cytochrome P-450p-2)
18. P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease
19. Prospective cytochrome P450 phenotyping for neuroleptic treatment in dementia
20. Particular ability of liver P450s3A to catalyze the oxidation of N omega-hydroxyarginine to citrulline and nitrogen oxides and occurrence in no synthases of a sequence very similar to the heme-binding sequence in P450s
21. Catalytic properties of rabbit kidney fatty acid omega-hydroxylase cytochrome P-450ka2 (CYP4A7)
22. High-performance liquid chromatographic method for the analysis of imipramine metabolism in vitro by liver and brain microsomes
23. Cloning and characterization of a novel member of the cytochrome P450 subfamily IVA in rat prostate
24. Isolation of partially purified P450 2D18 and characterization of activity toward the tricyclic antidepressants imipramine and desipramine
25. cDNA cloning and expression of the mRNA for cytochrome P-450kd which shows a fatty acid omega-hydroxylating activity
26. 4′-alkylated analogs of 1-methyl-4-phenylpyridinium ion are potent inhibitors of mitochondrial respiration